POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 63 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,078,929 | +201.8% | 2,554,172 | +123.2% | 0.00% | +200.0% |
Q2 2023 | $2,014,058 | +66923.6% | 1,144,351 | +17.3% | 0.00% | -50.0% |
Q1 2023 | $3,005 | -65.6% | 975,612 | -40.8% | 0.00% | -60.0% |
Q4 2022 | $8,729 | -98.4% | 1,646,897 | +984.9% | 0.01% | – |
Q3 2022 | $536,000 | -79.5% | 151,798 | -85.0% | 0.00% | -100.0% |
Q2 2022 | $2,612,000 | -30.1% | 1,012,515 | +21.3% | 0.00% | 0.0% |
Q1 2022 | $3,739,000 | -38.8% | 834,586 | -6.9% | 0.00% | -33.3% |
Q4 2021 | $6,105,000 | -8.0% | 896,514 | -1.5% | 0.00% | -25.0% |
Q3 2021 | $6,633,000 | -36.7% | 909,856 | -13.0% | 0.00% | -33.3% |
Q2 2021 | $10,482,000 | -37.8% | 1,046,123 | -40.7% | 0.01% | -50.0% |
Q1 2021 | $16,851,000 | +4.2% | 1,764,505 | +19.7% | 0.01% | 0.0% |
Q4 2020 | $16,176,000 | +291.0% | 1,474,529 | +216.1% | 0.01% | +140.0% |
Q3 2020 | $4,137,000 | – | 466,459 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
Atom Investors LP | 156,168 | $371,680 | 0.08% |
Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
RBF Capital, LLC | 70,171 | $167,007 | 0.01% |